Argá Medtech

Epalinges, Switzerland Founded: 2020 • Age: 6 yrs
Medical devices for cardiac arrhythmias are developed by Argá Medtech.
Request Access

About Argá Medtech

Argá Medtech is a company based in Epalinges (Switzerland) founded in 2020 by David Neale and Randy Werneth.. Argá Medtech has raised $58.52 million across 1 funding round from investors including Advent Life Sciences, Earlybird and Gilde Healthcare. Argá Medtech offers products and services including Pulsed Field Ablation System and Proprietary Catheter. Argá Medtech operates in a competitive market with competitors including Kardium, Adagio Medical, Farapulse, Affera and Field Medical, among others.

  • Headquarter Epalinges, Switzerland
  • Founders David Neale, Randy Werneth
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Argá Medtech Sa
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $58.52 M (USD)

    in 1 rounds

  • Latest Funding Round
    $58.52 M (USD), Series B

    Feb 27, 2024

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Argá Medtech

Argá Medtech offers a comprehensive portfolio of products and services, including Pulsed Field Ablation System and Proprietary Catheter. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Non-thermal system for safe cardiac ablation to treat arrhythmias.

Catheter designed for versatile use in ablation procedures.

People of Argá Medtech
Headcount 1-10
Employee Profiles 2
Employee Profiles
People
Randy Werneth
CTO
People
David Neale
CEO

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of Argá Medtech

Argá Medtech has successfully raised a total of $58.52M through 1 strategic funding round. The most recent funding activity was a Series B round of $58.52 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series B — $58.5M
  • First Round

    (27 Feb 2024)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Feb, 2024 Amount Series B - Argá Medtech Valuation Advent Life Sciences , Earlybird
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Argá Medtech

Argá Medtech has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Advent Life Sciences, Earlybird and Gilde Healthcare. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Early and mid-stage life science focused VC firm investing in the US and Europe
Founded Year Domain Location
Earlybird is recognized as a venture capital investor focused on early-stage tech companies.
Founded Year Domain Location
Private equity and venture captial firm focused on healthcare sectors
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Argá Medtech

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Argá Medtech

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Argá Medtech Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Argá Medtech

Argá Medtech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kardium, Adagio Medical, Farapulse, Affera and Field Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Atrial fibrillation ablation devices are developed by Kardium.
domain founded_year HQ Location
Cardiovascular therapies are developed by Adagio Medical in stealth mode.
domain founded_year HQ Location
Devices for cardiac ablation via pulsed field technology are developed.
domain founded_year HQ Location
Devices for treating heart rhythm disorders are developed.
domain founded_year HQ Location
Pulsed electric field ablation devices for heart arrhythmias are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Argá Medtech

Frequently Asked Questions about Argá Medtech

When was Argá Medtech founded?

Argá Medtech was founded in 2020 and raised its 1st funding round 4 years after it was founded.

Where is Argá Medtech located?

Argá Medtech is headquartered in Epalinges, Switzerland. It is registered at Epalinges, Vaud, Switzerland.

Who is the current CEO of Argá Medtech?

David Neale is the current CEO of Argá Medtech. They have also founded this company.

Is Argá Medtech a funded company?

Argá Medtech is a funded company, having raised a total of $58.52M across 1 funding round to date. The company's 1st funding round was a Series B of $58.52M, raised on Feb 27, 2024.

What does Argá Medtech do?

Argá Medtech was founded in 2020 and is based in Epalinges, Switzerland. Focus is placed on the development of medical devices within the cardiac health sector. Pulsed field ablation and irreversible electroporation technologies are advanced for arrhythmia treatment. Operations center on innovation in electrophysiology tools, with regulatory and clinical oversight managed internally to support device progression toward clinical applications.

Who are the top competitors of Argá Medtech?

Argá Medtech's top competitors include Kardium, Adagio Medical and Field Medical.

What products or services does Argá Medtech offer?

Argá Medtech offers Pulsed Field Ablation System and Proprietary Catheter.

Who are Argá Medtech's investors?

Argá Medtech has 3 investors. Key investors include Advent Life Sciences, Earlybird, and Gilde Healthcare.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available